Metformin, a more commonly used drug for T2DM, directly targets the H3K27me3 demethylase KDM6A and can reverse the H3K36me mark in prediabetic and diet-induced obesity mouse models [144,145]. The gene discussed is KDM6A; the disease is obesity due to melanocortin 4 receptor deficiency.